www.pharmafocusamerica.com
Open in
urlscan Pro
57.128.128.108
Public Scan
Submitted URL: http://www.pharmafocusamerica.com/
Effective URL: https://www.pharmafocusamerica.com/
Submission: On May 26 via manual from US — Scanned from FR
Effective URL: https://www.pharmafocusamerica.com/
Submission: On May 26 via manual from US — Scanned from FR
Form analysis 2 forms found in the DOM
POST https://www.pharmafocusamerica.com/search
<form method="POST" action="https://www.pharmafocusamerica.com/search" accept-charset="UTF-8"><input name="_token" type="hidden" value="dqFk3qbGimKfj1dGB4YbojahaqvmF7eYrT2vsqZ2">
<div class="input-group col-md-12" id="main-search"><input type="text" name="q" class="form-control input-md" id="autoComplete" required="" placeholder="Search..."><span class="input-group-btn"><button class="btn btn-secondary"
type="submit"><i class="fa fa-search" aria-hidden="true"></i></button></span></div>
</form>POST https://www.pharmafocusamerica.com/welcome
<form action="https://www.pharmafocusamerica.com/welcome" role="form" id="ebookform" method="post" accept-charset="utf-8"><input type="hidden" name="_token" value="dqFk3qbGimKfj1dGB4YbojahaqvmF7eYrT2vsqZ2">
<div class="form-group "><input type="email" name="email" placeholder="Your Mail ID..." id="inputEmail" data-error="Bruh, that email address is invalid" required=""
class="page_speed_1857846712 form-control bg-transparent border border-white PF-MagField"><span class="help-block"></span></div><input value="e-book" name="type" id="e-book" type="hidden"><input value="" name="ebook_script" id="ebook_script"
type="hidden"><button type="submit" id="submit" name="submit" class="btn btn-sm btn-block btn-danger"><img src="https://industry.pharmafocusamerica.com/images/submit.png" class="" alt="submit" title="submit"> SUBMIT </button>
</form>Text Content
* HOME (current) * EDITORIAL SECTION StrategyResearch & DevelopmentClinical TrialsManufacturingInformation Technology Expert Talk * GET PUBLISHED * MAGAZINE Previous Issuese-Book ArchivesForewordAuthor GuidelinesAdvisory BoardEditorial Calendar * KNOWLEDGE BANK ArticlesTechno TrendsProjectsResearch InsightsBook Shelf * INDUSTRY UPDATE NewsPress ReleasesEvents * ADVERTISE PrintOnlineTarget MarketTarget AudienceTech SpecsMediapackTerms * WEBINARS * SUBSCRIBE E-NEWSLETTER E-Newsletter Subscription MAGAZINE Magazine Subscription NEXT GENERATION SEQUENCINGGENOMICS USE OF ARTIFICIAL INTELLIGENCE IN AUTOMATION OF PHARMACOVIGILANCE HOW AI IS TRANSFORMING THE PHARMA INDUSTRY CONTINUOUS VS. BATCH MANUFACTURING ADVANCED MODEL PREDICTIVE CONTROL SYSTEM OF CONTINUOUS BIOPHARMACEUTICAL MANUFACTURING PROCESS ADAPTING CONTAINMENT STRATEGIES TO FUTURE-PROOF THE MANUFACTURE OF STERILE DRUG PRODUCTS VIRAL GENE THERAPY – HOW CAN THE INDUSTRY DRIVE DOWN THE COST OF GOODS TO BETTER SERVE THE PATIENTS? CHOOSE CAREFULLY: THE POTENTIAL OF CONTINUOUS FLOW CHEMISTRY IN API SYNTHESIS PHARMACEUTICAL 3D PRINTING GENE THERAPY FOR CANCER & IMMUNOLOGY DECENTRALIZATION - THE FUTURE OF CLINICAL TRIALS IGA-MEDIATED INFLAMMATORY DISORDERS USING QUANTITATIVE SYSTEMS PHARMACOLOGY MODELLING TO ACCELERATE DRUG DEVELOPMENT ADVANCES IN MRNA THERAPEUTICS AND VACCINES PreviousNext GET INSTANT ACCESS TO LATEST E-BOOK SUBMIT LATEST NEWSREAD MORE... 26 May 2023 TME PHARMA PROVIDES POSITIVE CLINICAL UPDATE AND 14-MONTH SURVIVAL DATA FROM GLORIA EXPANSION ARM EVALUATING NOX-A12 IN COMBINATION WITH RADIOTHERAPY AND BEVACIZUMAB IN GLIOBLASTOMA ME Pharma NV Euronext Growth Paris ALTME a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment TME announces clinical update on survival of newly diagnosed glioblastoma patients in the GLORIA expansion arm evaluating NOXA TME Ph... 26 May 2023 BIORAY HAS FILED AN IND FOR BRY812, A NOVEL ANTIBODY-DRUG CONJUGATE TARGETING LIV-1 BioRay Pharmaceutical Co hereafter referred to as BioRay announced that the Investigational New Drug IND application for the clinical trial of its proprietary product BRY a novel antibody drug ADC targeting human LIV for the treatment of advanced malignancies has been accepted by China National Med... 26 May 2023 PFIZER’S PAXLOVID™ RECEIVES FDA APPROVAL FOR ADULT PATIENTS AT HIGH RISK OF PROGRESSION TO SEVERE COVID-19 Pfizer Inc NYSE PFE announced today that the US Food and Drug Administration FDA approved PAXLOVID nirmatrelvir tablets and ritonavir tablets for the treatment of mildtomoderate COVID in adults who are at high risk for progression to severe COVID including hospitalization or death PAXLOVID has been... 26 May 2023 HI-BIO RECEIVES FDA ORPHAN DRUG DESIGNATION FOR FELZARTAMAB FOR THE TREATMENT OF MEMBRANOUS NEPHROPATHY Human Immunology Biosciences HIBio a clinicalstage biotechnology company developing targeted therapies for patients with severe immunemediated diseases IMDs today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD for felzartamab the companys investigation... 26 May 2023 MILVEXIAN GRANTED U.S. FDA FAST TRACK DESIGNATION FOR ALL THREE INDICATIONS UNDER EVALUATION IN PHASE 3 LIBREXIA PROGRAM: ISCHEMIC STROKE, ACUTE CORONARY SYNDROME AND ATRIAL FIBRILLATION The Janssen Pharmaceutical Companies of Johnson Johnson today announced that all three prospective indications for milvexian an investigational oral factor XIa FXIa inhibitor being developed in collaboration with Bristol Myers Squibb have now been granted Fast Track Designation by the US Food and D... 25 May 2023 10X GENOMICS LAUNCHES VISIUM CYTASSIST GENE AND PROTEIN EXPRESSION ASSAY x Genomics Inc Nasdaq TXG a leader in single cell and spatial biology announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities PRESS RELEASESREAD MORE... 26 May 2023 EMOLECULES ACQUIRES SPECS COMPOUND HANDLING B.V. EMolecules Inc an industry leading chemical compound searchandfulfillment platform for early discovery chemistry research today announced the acquisition of Specs Compound Handling BV Specs 26 May 2023 JNANA THERAPEUTICS ANNOUNCES MILESTONE ACHIEVED UNDER FIRST COLLABORATION WITH ROCHE Jnana Therapeutics a clinicalstage biotechnology company leveraging its nextgeneration chemoproteomics platform to discover medicines for challengingtodrug targets announces the achievement of a milestone from its first collaboration agreement with Roche SIXRO ROG OTCQX RHHBY 26 May 2023 DEBIOPHARM PARTNERS WITH GENEDATA TO DIGITALIZE TRANSLATIONAL RESEARCH Genedata the leading provider of enterprise software solutions for biopharmaceutical RD today announced that Debiopharm a Swissbased global biopharmaceutical company is adopting Genedata Profiler as its single point of access to translational research data to accelerate its RD activities and bring l... 26 May 2023 AION LABS, IN CONTINUED PARTNERSHIP WITH BIOMED X, LAUNCHES NEW GLOBAL CALL FOR APPLICATIONS: IDENTIFICATION OF ACTIVE SMALL MOLECULES FOR DRUG DISCOVERY AION Labs a firstofitskind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges and German independent research institute BioMed X announced today the launch of its latest global call for applications to identify AI and machine learnin... 26 May 2023 GINKGO BIOWORKS AND CENTRIENT PHARMACEUTICALS ANNOUNCE EXPANSION OF PARTNERSHIP FOLLOWING SUCCESS OF INITIAL PROJECT TO BRING SUSTAINABLE INNOVATION TO THE GENERIC API SPACE Centrient Pharmaceuticals Centrient the global businesstobusiness leader in sustainable antibiotics nextgeneration statins and antifungals and Ginkgo Bioworks NYSE DNA which is building the leading platform for cell programming and biosecurity today announced they are expanding their existing partne... 25 May 2023 VOYAGEUR PHARMACEUTICALS PARTNERS WITH RAIN CAGE CARBON TO REVOLUTIONIZE MEDICAL IMAGING WITH NANOCARBON-BASED CONTRAST DRUGS Voyageur Pharmaceuticals Ltd TSXV VM USA VYYRF Voyageur or the Corporation announces it has entered into a groundbreaking development and license agreement with Rain Cage Carbon Inc Rain Cage This strategic partnership aims to revolutionize the field by developing and manufacturing cuttingedge nanoc... EVENTSREAD MORE... 05 - 08 Jun 2023 BIO INTERNATIONAL CONVENTION Boston, United States 12 - 13 Jun 2023 PRE-FILLED SYRINGES WEST COAST San Diego, CA, USA 12 - 13 Jun 2023 PHARMACEUTICAL MANUFACTURING & PACKAGING CONGRESS Geneva, Switzerland 13 - 15 Jun 2023 FCE PHARMA – INTERNATIONAL Sao Paulo, Latin America 14 - 15 Jun 2023 RNA THERAPEUTICS USA San Diego, CA, USA 19 - 21 Jun 2023 CPHI & PMEC CHINA Shanghai, China 20 - 21 Jun 2023 CANNA PHARMA 2023 Philadelphia, United States 12 - 14 Jul 2023 CPHI SOUTH EAST ASIA Bangkok, Thailand TOP ARTICLES * 1 ALZHEIMER'S DRUG PIPELINE: PAST, PRESENT, AND FUTURE BIOLOGIC THERAPIES RONNY PRIEFER PROFESSOR, MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES UNIVERSITY CHAEHUI SUE PHARMACY STUDENT, MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES UNIVERSITY * 2 CANCER CELL-MEMBRANE-COATED NANOCARRIERS IN CANCER DIAGNOSIS AND TREATMENT: FROG-LEAPING INTO THE FUTURE RYAN VARGHESE STUDENT AND RESEARCHER, DEPARTMENT OF PHARMACEUTICAL CHEMISTRY, POONA COLLEGE OF PHARMACY, BHARATI VIDYAPEETH UNIVERSITY GARGI DIGHOLKAR POONA COLLEGE OF PHARMACY, BHARATI VIDYAPEETH UNIVERSITY JAINAM KARSIYA CLINICAL PHARMACIST AND MEDICAL AFFAIRS EXECUTIVE, RIVER ROUTE CREATIVE GROUP LLP DILEEP KUMAR POONA COLLEGE OF PHARMACY, BHARATI VIDYAPEETH (DEEMED TO BE) UNIVERSITY; DEPARTMENT OF ENTOMOLOGY, UNIVERSITY OF CALIFORNIA; UC DAVIS COMPREHENSIVE CANCER CENTER, UNIVERSITY OF CALIFORNIA. ELECTRONIC ADDRESS: DILEEP.0@GMAIL.COM * 3 ARTIFICIAL INTELLIGENCE IN CLINICAL TRIALS ASHWIN KUCHEKAR ASSOCIATE PROFESSOR AND THE HEAD OF CAREER SERVICES AND PLACEMENT AT THE SCHOOL OF PHARMACY REVA RAJENDRA JOSHI MASTERS STUDENT AT THE MIT WORLD PEACE UNIVERSITY SCHOOL OF PHARMACY * 4 MONKEY POX: A VIRAL DISEASE CREATING TREPIDATION BUT NOT PANDEMIC MANSI ATHALYE ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACEUTICS AT L. M. COLLEGE OF PHARMACY PARAG TARAPADA B. PHARM STUDENT, PHARMACY SECTION, L. M. COLLEGE OF PHARMACY NIJA PATEL B. PHARM STUDENT, PHARMACY SECTION, L. M. COLLEGE OF PHARMACY * 5 FORMULATION OF SESAMOL LOADED MANNOSE SURFACE CONJUGATED SMART LIPID PARTICLES: ASSESSMENT OF SERUM LIVER INJURY MARKERS VIPUL SANSARE DEPARTMENT OF PHARMACEUTICS, INDIRA INSTITUTE OF PHARMACY, INDIA PRASHANT GURAV DEPARTMENT OF PHARMACEUTICS, INDIRA INSTITUTE OF PHARMACY, INDIA MANISH KUMAR GUPTA SCHOOL OF PHARMACEUTICAL SCIENCES, JAIPUR NATIONAL UNIVERSITY, INDIA KNOWLEDGE BANK * ARTICLES ADVANCES IN MRNA THERAPEUTICS AND VACCINES Medicine is the testament to the virtue of human innovation a collective desire to reduce the burden of disease and an ever evolving journey to enhance the quality of human health ALZHEIMER'S DRUG PIPELINE: PAST, PRESENT, AND FUTURE BIOLOGIC THERAPIES Alzheimers disease AD is the most common type of dementia This is a progressive neurodegenerative disorder whereby cognitive and social abilities deteriorate over time and functioning suffers In the United States alone million individuals aged and older have AD with being years old or older The prevalence of AD is believed to be between and among the million persons with dementia globally CANCER CELL-MEMBRANE-COATED NANOCARRIERS IN CANCER DIAGNOSIS AND TREATMENT: FROG-LEAPING INTO THE FUTURE Cancer is one of the deadliest diseases known to exist in humans and is undoubtedly the leading cause of mortality worldwide The limited efficacy of the drug and the harmful side effects of conventional cancer therapy such as surgical therapy chemoradiotherapy and immunotherapy present a significant obstacle This leads to the development of new technologies ARTIFICIAL INTELLIGENCE IN CLINICAL TRIALS Artificial intelligence is a field of engineering and science that focus on making intelligent machines Artificial intelligence is a top technology that is reshaping the pharmaceutical industrys future For ages the pharmaceutical industry has been developing cures and treatments Traditionally medication design and manufacture took many years extensive clinical studies and skyhigh pricesThis has be... MONKEY POX: A VIRAL DISEASE CREATING TREPIDATION BUT NOT PANDEMIC Monkeypox is a viral disease that can be infected in humans and other animals by monkey pox virus It is the zoonotic virus that belongs to the genus Orthopoxvirus The variola virus which causes smallpox belongs to the same genus Monkey pox is infected in humans as two types first is the West African type and the second is the central African Congo Basin type FORMULATION OF SESAMOL LOADED MANNOSE SURFACE CONJUGATED SMART LIPID PARTICLES: ASSESSMENT OF SERUM LIVER INJURY MARKERS Liver diseases affect millions of populationworldwide which are difficult to treat with conventional drug deliveryBartneck et al World health organization has reported to of liver cirrhosisglobally due to alcohol consumption and more than million cases of chronic hepatitisinfections in Numerous drugs have been investigated for the treatment * RESEARCH INSIGHTS INTEGRATED BIOINFORMATICS AND STATISTICAL APPROACHES TO EXPLORE MOLECULAR BIOMARKERS FOR BREAST CANCER DIAGNOSIS, PROGNOSIS AND THERAPIES Integrated bioinformatics and statistical approaches are now playing the vital role in identifying potential molecular biomarkers more accurately in presence of huge number of alternatives for disease diagnosis prognosis and therapies by reducing time and cost compared to the wetlab based experimental procedures * TECHNO TRENDS NEW MEDICATION FOR TREATMENT OF ADULTS WITH SEVERE ALOPECIA AREATA (AA) OLUMIANT baricitinib a novel drug from Eli Lilly Company and Incyte has been introduced for the treatment of individuals with severe alopecia areata AA The proposed drug has yet to be approved by European regulators If approved Olumiant will be the first centrally sanctioned oral medicine ADVISORY BOARD Tamara Miller Juris Hmelnickis David Contorno Svetlana Busiguina Eiman Shafa Nigel Cryer FRSC . Hector Alejandro Andonie . Josipa Ljubicic . JOAQUÍN D. CAMPBELL . Hoda Gamal . Amine Bekkali . Pinheiro Neto João . EDITORIAL SECTION * STRATEGY AN OVERVIEW OF CLINICAL OVERVIEW A Clinical Overview is an integrated document intended to provide critical analysis of Pharmacology Efficacy and Safety of the pharmaceutical agent in humans It is one of the important documents of Module of the Common Technical Document CTD ie Module which refers to the data provided in the comprehensive clinical summary the individual clinical study reports presen... * RESEARCH DEVELOPMENT IGA-MEDIATED INFLAMMATORY DISORDERS In current drug development we are educated and trained to follow identical development strategies that have been proven to be successful in the past and assume a guaranteed success for the future * CLINICAL TRIALS GENE THERAPY FOR CANCER & IMMUNOLOGY After the s and the development of recombinant DNA techniques tests showed that foreign genes are able to correct disease phenotypes and genetic defects in mammalian cells while the use of gene transfer methods has facilitated the effective demonstration of phenotype correction in vitro and in vivo * MANUFACTURING CONTINUOUS VS. BATCH MANUFACTURING In batch processing a subsequent batch can be processed only after the current batch has been completed * INFORMATION TECHNOLOGY USE OF ARTIFICIAL INTELLIGENCE IN AUTOMATION OF PHARMACOVIGILANCE With rapid digitalization and increased research in the sector the pharmaceutical industry has experienced a remarkable development in the last three years opening doors for innovative routes of therapy for humankind * EXPERT TALK NEXT GENERATION SEQUENCING - GENOMICS The genomic sequencing approach allows for a comprehensive analysis of human DNA for gene sequence changes enabling the detection of cancer associated... A PRODUCT OF Ochre Media Pvt Ltd. QUICK LINKS * * Latest e-Book * Editorial Calendar * Subscribe for e-Newsletter * Advertise * Event Posting * Download Mediapack * Subscribe for Magazine * * About Us * Contact Us * * Terms & Conditions * Our Other Industries GET IN TOUCH © 2023 Ochre Media Pvt Ltd. All Rights Reserved ×